INS and diabetes mellitus: Kirby-Smith et al. (2023) [41] have recently reported a study on AV polysaccharides in microparticle formulations, which significantly improved nasal insulin delivery, used for the treatment of Alzheimer’s disease (AD) and diabetes mellitus (DM).